Meeting
2019 Breakthrough
Metformin, aspirin and statin and risk of cancer: A population-based study in Thailand.
Authors
Songporn Oranratnachai
Ramathibodi Hospital, Bangkok, Chiang Mai, Thailand
Songporn Oranratnachai , Nisakorn Thongmung , Piyaporn Phetchoo , Sasivimol Rattanasiri , Ammarin Thakkinstian , Somthawin Lukerak , Prin Vathesatogkit , Narumol Trachu , Piyamitr Sritara , Ekaphop Sirachainan , Thanyanan Reungwetwatttana
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Access to Care, Diagnostics, Early Detection and Diagnosis, Prevention and Screening, and Surveillance
Track
Access to Care,Diagnostics,Early Detection and Diagnosis,Prevention and Screening,Surveillance
Sub Track
Prevention and Screening
Citation
J Glob Oncol 5, 2019 (suppl 1; abstr 65)
DOI
10.1200/JGO.2019.5.suppl.65
Abstract #
65
Poster Bd #
E5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Secondary analysis of the SPARTAN trial.
First Author: Soumyajit Roy
Poster
2020 ASCO Virtual Scientific Program
Malignancies associated with DPP4 inhibitors and GLP1 receptor agonists: Data from a large real-world database.
First Author: Jiasheng Wang
Poster
2024 ASCO Genitourinary Cancers Symposium
Effect of concomitant medications on treatment response and survival in de novo metastatic prostate cancer: Secondary analysis of the LATITUDE study.
First Author: Soumyajit Roy
Poster
2023 ASCO Annual Meeting
Metformin for chemoprevention of lung cancer in high-risk overweight or obese individuals.
First Author: Isra Nour